Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors Acta Pharmacologica Sinica Cagrilintide Vial (10mg) High Purity Peptide Pure Bio Labs In the REDEFINE 1 phase 3a trial, semaglutide at a dose of 2.4 mg with cagrilintide at a dose of 2.4 mg led to significant body weight reduction in adults without diabetes and Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors Nature Communications